BioWorld™ delivers actionable intelligence on the most innovative drug development science across the industry. With writers and editors stationed around the globe, BioWorld reports the breaking news – and provides key perspectives – on hundreds of medicines in development, the companies behind those therapeutic candidates, the business development transactions that evolve the market, and the regulatory hurdles that both challenge and guard the process.
Build smart businesses that advance novel science to improve the human condition. Deeply experienced journalists cut through the clutter to deliver unbiased, critical news and analysis, enriched with insightful data from Cortellis™, the comprehensive suite of life science intelligence solutions from Clarivate Analytics.
Zero in on key markets and emerging trends, information curated by writers and editors stationed around the globe. Regulatory reports help you manage the hurdles that both challenge and guard the processes to bring new therapies to market. In addition, the BioWorld team is on the ground at key industry conferences across the globe, covering breaking news from business and scientific sessions and examining behind-the-scenes activities.
In addition to getting original daily news reporting, mine an extensive searchable database at http://bioworld.com, which includes two decades’ worth of pharmaceutical and biopharmaceutical news archives. With a quick search, you’ll have instant access to a wealth of market intelligence from around the globe.
Take advantage of BioWorld Snapshots – exclusive online summaries updated daily with market data such as collaborations, mergers, acquisitions, financings, market cap rankings and more.
Want to partner with us to create value-added solutions?